Skip to main content
Premium Trial:

Request an Annual Quote

Taiwan Research Institute Funds Isis SARS Antisense Research

NEW YORK, June 24 - Isis Pharmaceuticals is beginning a search for antisense therapies to the SARS coronavirus, which the Industrial and Technology Research Institute of Taiwan is funding with $2 million, the organizations said today.


Initially, the goal is to identify at least one SARS antisense drug, and then develop intravenous and aerosol forms of the drug to prepare for preclinical toxicology studies.


Isis, of Carlsbad, Calif., has already synthesized about 200 antisense compounds that inhibit regions of the SARS coronavirus sequences. These stretches of sequence are conserved across all known sequences of the SARS coronavirus.


ITRI is a non-profit research institute funded by the Taiwanese government.

The Scan

Purnell Choppin Dies

Purnell Choppin, a virologist who led the Howard Hughes Medical Institute, has died at 91, according to the Washington Post.

Effectiveness May Decline, Data From Israel Suggests

The New York Times reports that new Israeli data suggests a decline in Pfizer-BioNTech SARS-CoV-2 vaccine effectiveness against Delta variant infection, though protection against severe disease remains high.

To See Future Risk

Slate looks into the use of polygenic risk scores in embryo screening.

PLOS Papers on Methicillin-Resistant Staphylococcus, Bone Marrow Smear Sequencing, More

In PLOS this week: genomic analysis of methicillin-resistant Staphylococcus pseudintermedius, archived bone marrow sequencing, and more.